Pegaptanib sodium
- 1 March 2005
- journal article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 4 (3) , 187-188
- https://doi.org/10.1038/nrd1677
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pegaptanib for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2004
- Causes and Prevalence of Visual Impairment Among Adults in the UnitedStatesArchives of Ophthalmology (1950), 2004
- Ophthalmic drug discoveryNature Reviews Drug Discovery, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision LossArchives of Ophthalmology (1950), 2001
- Age-Related Macular DegenerationNew England Journal of Medicine, 2000
- 2′-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165)Journal of Biological Chemistry, 1998
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994